Immunocore and MEPC have announced a 53,000 sq ft expansion at Milton Park in Oxfordshire.
MEPC will provide the drug developer with a purpose-built research laboratory and facilities. It has been based at Milton Park since
Immunocore and MEPC have announced a 53,000 sq ft expansion at Milton Park in Oxfordshire.
MEPC will provide the drug developer with a purpose-built research laboratory and facilities. It has been based at Milton Park since
Our mission is to support you in finding and assessing investment and development opportunities faster.
Help us do just that by taking part in an exclusive product testing session.
Sign up nowKind regards,
The EG team